|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.2750 - 1.3400|
|52 Week Range||1.1900 - 4.7800|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||5.08|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
TORONTO , Oct. 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, will report its second quarter fiscal year 2020 financial results before markets open on Thursday, November 14, 2019 . Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC), which are currently scheduled to be released on November 14, 2019 .
James E. Wagner Cultivation (TSXV: JWCA) (OTCQX: JWCAF), a portfolio company of Canopy Rivers (TSX: RIV) (OTC: CNPOF), has been granted approval by Health Canada to increase cannabis production at its facility in Kitchener, Ontario. The approval allows the company to start the production in four new flowering rooms at its facility in Kitchener. The additional […]The post Canopy Rivers Gets Approval to Boost Cannabis Production appeared first on Market Exclusive.
TORONTO, Oct. 7, 2019 /PRNewswire/ - Canopy Rivers Inc. (the "Canopy Rivers") (TSX: RIV, OTC: CNPOF) today announced that its portfolio company, TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF) has received approval from Health Canada for a significant expansion at its Mississauga, Ontario facility. TerrAscend expects that this milestone will help the company meet the increased consumer demand for premium cannabis products and brands coming with the next wave of Canadian cannabis legalization. As the first and only cannabis company with sales in Canada, the U.S., and Europe, TerrAscend has also earmarked the additional capacity to further serve the global markets where it operates.
More than 800 cannabis companies have signed a letter asking Congress to deschedule marijuana, Marijuana Moment reported Thursday. The letter submitted to House and Senate leadership Thursday said the vaping situation demands strict federal regulations that are only possible once marijuana is removed from the federal schedule of controlled substances. The National Cannabis Industry Association was the main driver behind the letter, which also emphasizes that most of the medical issues in question were caused by the use of unregulated products.
The principal amount of the Debentures is convertible into fully paid and non-assessable common shares of TerrAscend ("Common Shares") or exchangeable shares of TerrAscend ("Exchangeable Shares") at the option of the holder or upon the occurrence of certain events at a conversion price of $5.95 per share.
TerrAscend Corp. (CSE: TER) (OTC: TRSSF ) said Wednesday it plans to conclude non-brokered private placement offerings to raise $25 million by issuing units of both TerrAscend and TerrAscend Canada Inc. ...
TORONTO , Oct. 2, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, has completed a US $10 million investment (the "Investment") in TerrAscend Canada Inc. ("TerrAscend Canada"), a subsidiary of its portfolio company TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF). The investment includes the purchase of 13,243 units, with each unit consisting of: (i) one unsecured convertible debenture of TerrAscend Canada with a principal amount of CA $1,000 (the "Debentures"), and (ii) 25.2 common share purchase warrants of TerrAscend exercisable until October 2, 2024 (the "Warrants").
TORONTO , Sept. 26, 2019 /PRNewswire/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced ...
When asked about the recent announcement involving Convectium/Jacksam, Mr. Ralston commented, "Convectium was founded on the basis that automation, speed, hardware and technology combined for the ancillary cannabis space can really help these manufacturers and retailers make their whole filling and supply chain process much simpler and efficient. Discussing what separates Convectium from some of their competitors, Ralston said, "Right now Convectium, in our opinion, is really leading the way because they check all the boxes for what a company may need when it comes to filling and getting these automation systems set up. SinglePoint Inc. will also be presenting their Pure Hemp Cigarettes next month at NACS on October 1st - 4th at booth 5653.
TORONTO, Sept. 17, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF), a venture capital firm specializing in cannabis, is pleased to announce its portfolio company, TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF), has entered into a distribution agreement with Syqe Medical, Ltd. ("Syqe"), an Israel-based pharma-tech company, to launch Syqe's flagship product, the Syqe™ Inhaler, in Canada. The Syqe Inhaler is the world's first metered-dose medical cannabis inhaler and will provide Canadians with an alternative to dried flower medical cannabis.
Formerly ousted Canopy Growth co-CEO Bruce Linton is getting back into the cannabis space with new advisor and investor positions.
TORONTO, Sept. 11, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF), a venture capital firm specializing in cannabis, is pleased to announce the formation of its Strategic Advisory Board, a group of respected business leaders that will provide guidance to Canopy Rivers' executive team as it continues to build and strengthen the Company's global portfolio of leading cannabis companies. "We have assembled a group of outstanding individuals with exceptional track records as leaders in their respective industries," said Narbe Alexandrian, President and CEO of Canopy Rivers.
Canopy Rivers Portfolio Company Herbert Works Awarded R&D Licence from Health Canada to Develop Cannabis-Infused Beverages
SAN DIEGO, Sept. 10, 2019 /PRNewswire/ -- ZeaKal, a plant traits innovator focused on improving crop efficiency, is aggressively expanding to meet the global demand for more sustainable agriculture. Building on recent collaborations with Canopy Rivers Inc. (TSXV: RIV, OTC: CNPOF) and Corteva Agriscience (CTVA), the company today announced the close of its Series C financing round and the addition of Paul Schickler, former president of DuPont Pioneer, to its leadership team. Existing investors including Finistere Ventures and Middleland Capital participated in the round, and Finistere tapped its extensive industry network to find the ideal fit for ZeaKal's strategic needs.
TORONTO , Sept. 9, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF), a venture capital firm specializing in cannabis, is pleased to announce that, as of the opening of the markets today, its class A subordinated voting shares will begin trading on the Toronto Stock Exchange (the "TSX") under the ticker symbol "RIV". This milestone was achieved within less than one year of Canopy Rivers' initial go-public transaction. "We are proud to join a class of issuers that includes many reputable domestic and international companies," said Narbe Alexandrian, President and CEO of Canopy Rivers. On September 24, 2019 , Canopy Rivers will participate in the TSX market open ceremony.